Characteristics and clinical outcomes of patients with sarcoidosis admitted for ST-elevation myocardial infarction in the United States: a propensity matched analysis from the National Inpatient Sample
- PMID: 38846054
- PMCID: PMC11155460
- DOI: 10.5114/amsad/184701
Characteristics and clinical outcomes of patients with sarcoidosis admitted for ST-elevation myocardial infarction in the United States: a propensity matched analysis from the National Inpatient Sample
Abstract
Introduction: Sarcoidosis is a systemic inflammatory disorder characterised by non-caseating granulomas. Cardiac sarcoidosis (CS) normally causes conduction abnormalities, ventricular arrhythmias, and heart failure. Little is known about the characteristics and impact of sarcoidosis in patients admitted with ST-elevation myocardial infarction (STEMI). This study aims to fill this void.
Material and methods: Utilising the National Inpatient Sample (NIS) database (2016-2020), individuals with STEMI were identified and categorised based on sarcoidosis presence whilst adjusting for confounders via logistic regression models.
Results: Among 851,290 STEMI patients, 1215 had sarcoidosis. Before propensity matching, sarcoidosis patients were notably different in demographics and comorbidities compared to non-sarcoidosis patients. After propensity score matching (PSM), sarcoidosis patients were found to have a higher incidence of supraventricular tachycardia (SVT) (2.5% vs. 1.3%, p = 0.024) and acute kidney injury (AKI) (23.3% vs. 20.8%, aOR = 1.269, 95% CI: 1.02-1.58, p = 0.033) but a lower incidence of undergoing coronary artery bypass graft (CABG) (5.5% vs. 8.5%, aOR = 0.663; 95% CI: 0.472-0.931, p = 0.018), while no significant disparities were noted in PCI, cardiogenic shock, mortality, or mean length of stay (LOS).
Conclusions: Using propensity-matched large real-world data of STEMI patients, sarcoidosis was associated with fewer cases of CABG and a greater incidence of AKI and SVT compared to non-sarcoidosis patients.
Keywords: ST-elevation myocardial infarction; cardiac sarcoidosis; propensity matched; sarcoidosis.
Copyright: © 2024 Termedia & Banach.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Clinical outcomes following hospitalization for COVID-19 in patients with cardiac sarcoidosis in the United States: a propensity-matched analysis from national inpatient sample database from April 2020 to December 2021.Ann Med Surg (Lond). 2024 Aug 22;86(10):5696-5703. doi: 10.1097/MS9.0000000000002474. eCollection 2024 Oct. Ann Med Surg (Lond). 2024. PMID: 39359767 Free PMC article.
-
Racial disparities among patients with cardiac sarcoidosis and arrhythmias in the United States: A propensity matched-analysis from the national inpatient sample database 2016-2020.Curr Probl Cardiol. 2024 Apr;49(4):102450. doi: 10.1016/j.cpcardiol.2024.102450. Epub 2024 Feb 13. Curr Probl Cardiol. 2024. PMID: 38355077
-
Early versus delayed coronary artery bypass graft surgery for patients with non-ST elevation myocardial infarction.Coron Artery Dis. 2017 Dec;28(8):670-674. doi: 10.1097/MCA.0000000000000537. Coron Artery Dis. 2017. PMID: 28723830
-
Impact of COVID-19 on Outcomes of Patients Hospitalized With STEMI: A Nationwide Propensity-matched Analysis.Curr Probl Cardiol. 2023 Apr;48(4):101547. doi: 10.1016/j.cpcardiol.2022.101547. Epub 2022 Dec 14. Curr Probl Cardiol. 2023. PMID: 36528206 Free PMC article. Review.
-
Cardiovascular Outcomes of Redo-coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention of Index Bypass Grafts Among Acute Coronary Syndrome: Regression Matched National Cohort Study.Curr Probl Cardiol. 2023 May;48(5):101580. doi: 10.1016/j.cpcardiol.2022.101580. Epub 2023 Jan 4. Curr Probl Cardiol. 2023. PMID: 36608781 Review.
Cited by
-
Characteristics and outcomes of hospitalized patients with Isolated and systemic cardiac sarcoidosis: Analysis of the Nationwide readmissions database 2016-2021.Int J Cardiol Heart Vasc. 2025 Feb 24;57:101636. doi: 10.1016/j.ijcha.2025.101636. eCollection 2025 Apr. Int J Cardiol Heart Vasc. 2025. PMID: 40092564 Free PMC article.
-
Clinical outcomes following hospitalization for COVID-19 in patients with cardiac sarcoidosis in the United States: a propensity-matched analysis from national inpatient sample database from April 2020 to December 2021.Ann Med Surg (Lond). 2024 Aug 22;86(10):5696-5703. doi: 10.1097/MS9.0000000000002474. eCollection 2024 Oct. Ann Med Surg (Lond). 2024. PMID: 39359767 Free PMC article.
References
-
- Bokhari SRA, Zulfiqar H, Mansur A. Sarcoidosis. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430687/
-
- Mahmoud AR, Dahy A, Dibas M, Abbas AS, Ghozy S, El-Qushayri AE. Association between sarcoidosis and cardiovascular comorbidity: a systematic review and meta-analysis. Heart Lung 2020; 49: 512-7. - PubMed
-
- Hussain K, Shetty M. Cardiac sarcoidosis. [Updated 2023 Jan 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK578192/ - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous